Bacteria naturally release microscopic particles known as bacterial extracellular vesicles. This review considers how these vesicles could be adapted for precision cancer medicine, from carrying drugs and activating immune responses to limiting metastasis and identifying cancer biomarkers. It also examines the practical obstacles ahead, including inconsistent production, safety risks, contamination and the lack of shared manufacturing and quality standards.

L'Oréal Groupe and NUS Medicine integrate skin, scalp and hair health into longevity research

Medical devices for point-of-care diagnosis need to be small and fast. Researchers from TMOS have designed and built a first-of-its-kind optical surface for developing ultracompact devices that can image transparent samples, such as cells. Their new device reduces the need for large supporting components by embedding multiple functions in a single surface and selecting them externally using the wavelength and polarisation of light illuminating a sample. This new approach presents a novel design philosophy in nanophotonics.

In a new Nature study published on August 10, 2026, Scripps Research scientists developed Dyna-1, a machine learning (ML) model that can predict protein dynamics on the micro-to-millisecond timescale. In seconds, Dyna-1 identifies regions of proteins likely to undergo these movements, revealing aspects of protein function that have remained hidden from conventional computational approaches. Because these micro-to-millisecond dynamics are particularly conserved across biology since they control function, mapping them could help researchers uncover new connections between protein movement and human health.

NYU Langone Health has appointed Nadia Ovchinsky, MD, an internationally recognized pediatric hepatologist, as the Pat and John Rosenwald Professor of Pediatrics and chair of the Department of Pediatrics at NYU Grossman School of Medicine.

BUFFALO, NY – August 10, 2026 – A new research paper was published in Volume 17 of Oncotarget on August 7, 2026, titled “Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers.”